Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) plus pembrolizumab (pembro) plus carboplatin (carbo) +/- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC)

Simple item page
dc.contributor.authorVergote, Ignace
dc.contributor.authorMirza, Mansoor Raza
dc.contributor.authorSehouli, Jalid
dc.contributor.authorLorusso, Domenica
dc.contributor.authorOse, Fatih K.
dc.contributor.authorCibula, David
dc.contributor.authorWestermann, Anneke M.
dc.contributor.authorCollins, Dearbhaile Catherine
dc.contributor.authorBanerjee, Susana N.
dc.contributor.authorOaknin, Ana
dc.contributor.authorSoumaoro, Ibrahima
dc.contributor.authorJain, Shweta
dc.contributor.authorMonk, Bradley J.
dc.date.accessioned2022-11-04T11:46:36Z
dc.date.available2022-11-04T11:46:36Z
dc.date.issued2022
dc.identifier.issn0732-183Xen_US
dc.identifier.issue16en_US
dc.identifier.urihttp://hdl.handle.net/11727/8010
dc.identifier.volume40en_US
dc.identifier.wos000863680305002en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTrial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) plus pembrolizumab (pembro) plus carboplatin (carbo) +/- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC)en_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar